Cullinan Therapeutics Inc (CGEM)
26.56
-0.61
(-2.25%)
USD |
NASDAQ |
May 10, 16:00
27.09
+0.53
(+2.00%)
After-Hours: 20:00
Cullinan Therapeutics Price to Book Value: 2.521 for May 10, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 09, 2024 | 2.579 |
| May 08, 2024 | 2.631 |
| May 07, 2024 | 2.786 |
| May 06, 2024 | 2.696 |
| May 03, 2024 | 2.691 |
| May 02, 2024 | 2.618 |
| May 01, 2024 | 2.667 |
| April 30, 2024 | 2.564 |
| April 29, 2024 | 2.574 |
| April 26, 2024 | 2.402 |
| April 25, 2024 | 1.827 |
| April 24, 2024 | 1.793 |
| April 23, 2024 | 1.582 |
| April 22, 2024 | 1.484 |
| April 19, 2024 | 1.486 |
| April 18, 2024 | 1.714 |
| April 17, 2024 | 1.697 |
| April 16, 2024 | 1.644 |
| April 15, 2024 | 1.571 |
| April 12, 2024 | 1.582 |
| April 11, 2024 | 1.649 |
| April 10, 2024 | 1.619 |
| April 09, 2024 | 1.616 |
| April 08, 2024 | 1.614 |
| April 05, 2024 | 1.616 |
| Date | Value |
|---|---|
| April 04, 2024 | 1.583 |
| April 03, 2024 | 1.633 |
| April 02, 2024 | 1.613 |
| April 01, 2024 | 1.675 |
| March 28, 2024 | 1.617 |
| March 27, 2024 | 1.683 |
| March 26, 2024 | 1.593 |
| March 25, 2024 | 1.607 |
| March 22, 2024 | 1.574 |
| March 21, 2024 | 1.551 |
| March 20, 2024 | 1.474 |
| March 19, 2024 | 1.471 |
| March 18, 2024 | 1.454 |
| March 15, 2024 | 1.512 |
| March 14, 2024 | 1.605 |
| March 13, 2024 | 1.612 |
| March 12, 2024 | 1.608 |
| March 11, 2024 | 1.525 |
| March 08, 2024 | 1.594 |
| March 07, 2024 | 1.552 |
| March 06, 2024 | 1.688 |
| March 05, 2024 | 1.717 |
| March 04, 2024 | 1.737 |
| March 01, 2024 | 1.757 |
| February 29, 2024 | 1.753 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.7132
Minimum
May 18 2023
11.68
Maximum
Mar 10 2021
1.924
Average
1.182
Median
Apr 11 2022
Price to Book Value Benchmarks
| Fate Therapeutics Inc | 1.100 |
| Viking Therapeutics Inc | 8.697 |
| Allogene Therapeutics Inc | 0.9094 |
| Applied Therapeutics Inc | -- |
| Nkarta Inc | 1.616 |
Price to Book Value Related Metrics
| Price | 26.56 |
| Earnings Yield | -13.89% |
| Market Cap | 1.144B |